164 related articles for article (PubMed ID: 29371559)
1. The Effect of Novel Heterocyclic Compounds on Cryptococcal Biofilm.
Korem M; Kagan S; Polacheck I
J Fungi (Basel); 2017 Jul; 3(3):. PubMed ID: 29371559
[TBL] [Abstract][Full Text] [Related]
2. In vitro Antifungal Activity of a Novel Antimicrobial Peptide AMP-17 Against Planktonic Cells and Biofilms of
Yang L; Tian Z; Zhou L; Zhu L; Sun C; Huang M; Peng J; Guo G
Infect Drug Resist; 2022; 15():233-248. PubMed ID: 35115792
[TBL] [Abstract][Full Text] [Related]
3. Anthraquinones against
Araújo GDS; Brilhante RSN; Rocha MGD; Aguiar L; Castelo-Branco DSCM; Guedes GMM; Sidrim JJC; Pereira Neto WA; Rocha MFG
J Med Microbiol; 2024 Mar; 73(3):. PubMed ID: 38530134
[No Abstract] [Full Text] [Related]
4. Anti-Candida albicans biofilm effect of novel heterocyclic compounds.
Kagan S; Jabbour A; Sionov E; Alquntar AA; Steinberg D; Srebnik M; Nir-Paz R; Weiss A; Polacheck I
J Antimicrob Chemother; 2014 Feb; 69(2):416-27. PubMed ID: 24078467
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Martinez LR; Casadevall A
Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265
[TBL] [Abstract][Full Text] [Related]
6. Antifungal activity of promethazine and chlorpromazine against planktonic cells and biofilms of Cryptococcus neoformans/Cryptococcus gattii complex species.
Brilhante RSN; Gotay WJP; Pereira VS; de Oliveira JS; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
Med Mycol; 2020 Oct; 58(7):906-912. PubMed ID: 32016364
[TBL] [Abstract][Full Text] [Related]
7. Biofilm Formation by Cryptococcus neoformans.
Martinez LR; Casadevall A
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185073
[TBL] [Abstract][Full Text] [Related]
8. Antifungal and Antibiofilm Efficacy of Paeonol Treatment Against Biofilms Comprising
Qian W; Li X; Liu Q; Lu J; Wang T; Zhang Q
Front Cell Infect Microbiol; 2022; 12():884793. PubMed ID: 35669114
[TBL] [Abstract][Full Text] [Related]
9. Darunavir inhibits
Brilhante RSN; Silva JAT; Araújo GDS; Pereira VS; Gotay WJP; Oliveira JS; Guedes GMM; Pereira-Neto WA; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
J Med Microbiol; 2020 Jun; 69(6):830-837. PubMed ID: 32459616
[No Abstract] [Full Text] [Related]
10. EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans.
Robertson EJ; Wolf JM; Casadevall A
Appl Environ Microbiol; 2012 Nov; 78(22):7977-84. PubMed ID: 22941091
[TBL] [Abstract][Full Text] [Related]
11. The use of chitosan to damage Cryptococcus neoformans biofilms.
Martinez LR; Mihu MR; Han G; Frases S; Cordero RJ; Casadevall A; Friedman AJ; Friedman JM; Nosanchuk JD
Biomaterials; 2010 Feb; 31(4):669-79. PubMed ID: 19819009
[TBL] [Abstract][Full Text] [Related]
12. Antifungal and antibiofilm effect of duloxetine hydrochloride against Cryptococcus neoformans and Cryptococcus gattii.
Rehem AR; da Gama Viveiro LR; De Souza Santos EL; do Carmo PHF; da Silva NS; Junqueira JC; Scorzoni L
Folia Microbiol (Praha); 2024 Apr; ():. PubMed ID: 38652436
[TBL] [Abstract][Full Text] [Related]
13. Quorum sensing-mediated, cell density-dependent regulation of growth and virulence in Cryptococcus neoformans.
Albuquerque P; Nicola AM; Nieves E; Paes HC; Williamson PR; Silva-Pereira I; Casadevall A
mBio; 2013 Dec; 5(1):e00986-13. PubMed ID: 24381301
[TBL] [Abstract][Full Text] [Related]
14. Antifungal and Anti-Biofilm Activity of Essential Oil Active Components against
Kumari P; Mishra R; Arora N; Chatrath A; Gangwar R; Roy P; Prasad R
Front Microbiol; 2017; 8():2161. PubMed ID: 29163441
[TBL] [Abstract][Full Text] [Related]
15. Anti-Cryptococcal activity of a furanone derivative-antibiofilm and opsonophagocytic potential.
Rathore SS; Raman T; Lalitha C; Ramar M; Munusamy A; Ramakrishnan J
J Mycol Med; 2020 Jun; 30(2):100924. PubMed ID: 32037102
[TBL] [Abstract][Full Text] [Related]
16. Disarming Fungal Pathogens:
Mayer FL; Kronstad JW
mBio; 2017 Oct; 8(5):. PubMed ID: 28974618
[TBL] [Abstract][Full Text] [Related]
17. Characterization of phenotypic switching in Cryptococcus neoformans biofilms.
Martinez LR; Ibom DC; Casadevall A; Fries BC
Mycopathologia; 2008 Oct; 166(4):175-80. PubMed ID: 18568421
[TBL] [Abstract][Full Text] [Related]
18. Antifungal and Antibiofilm In Vitro Activities of Ursolic Acid on Cryptococcus neoformans.
Wang WJ; Liu CC; Li YT; Li MQ; Fu YT; Li XC; Jie-Kang ; Qian WD
Curr Microbiol; 2022 Aug; 79(10):293. PubMed ID: 35972650
[TBL] [Abstract][Full Text] [Related]
19. Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B.
de Aguiar Cordeiro R; Mourão CI; Rocha MF; de Farias Marques FJ; Teixeira CE; de Oliveira Miranda DF; Neto LV; Brilhante RS; de Jesus Pinheiro Gomes Bandeira T; Sidrim JJ
Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):557-64. PubMed ID: 23192488
[TBL] [Abstract][Full Text] [Related]
20. Control of
Almeida-Apolonio AA; Cupozak-Pinheiro WJ; Berres VM; Dantas FGS; Svidzinski TIE; Oliveira KMP; Chang MR
ScientificWorldJournal; 2018; 2018():5764187. PubMed ID: 29977170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
